What is a fatty hilum in a lymph node or other structures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a Fatty Hilum?

A fatty hilum is the normal central echogenic (bright) or low-density fat-containing region within a lymph node that represents the entry and exit point for blood vessels and lymphatic channels—its presence is a key indicator of benign lymph node architecture. 1

Anatomic and Imaging Characteristics

The fatty hilum appears differently depending on the imaging modality used:

On Ultrasound

  • Appears as an echogenic (bright/hyperechoic) central region within the lymph node that represents normal fatty tissue, blood vessels, and lymphatic sinuses 2
  • The presence of this echogenic fatty hilum is one of the most reliable signs of a benign lymph node 1
  • Absence of the fatty hilum has a positive predictive value of 90-93% for malignancy in the context of breast cancer staging 1

On CT Imaging

  • Appears as a central low-density area (measuring fat density, typically -50 to -150 Hounsfield units) within the lymph node 2
  • Pathologic examination confirms this low-density hilum contains arteries, veins, lymphatic sinuses, and fatty tissue 2
  • The peripheral high-density cortex surrounding the hilum contains lymphatic tissue 2

On MRI

  • Described as loss of the normal fatty hilum when abnormal, appearing as rounded shape, heterogeneous signal, or loss of the characteristic fat signal 1
  • Normal nodes display characteristic fat signal in the hilar region on T1-weighted images 1

Clinical Significance in Malignancy Assessment

The fatty hilum serves as a critical discriminator between benign and malignant lymph nodes across multiple cancer types:

Breast Cancer

  • Absence of fatty hilum is the single most predictive ultrasound feature for axillary metastases with PPV of 90-93% 1
  • Other suspicious features include cortical thickness >0.3 cm and short-axis diameter >1 cm, but loss of fatty hilum is most specific 1
  • Even hypermetabolic lymph nodes on PET/CT that retain a fatty hilum may be reactive (such as post-vaccination) rather than metastatic 3

Vulvar Cancer

  • Absence of fatty hilum combined with irregular shape, cortical thickness ≥4 mm, and peripheral vascularization indicates lymph node metastases with sensitivity 76.3% and specificity 91.3% 1
  • Absent echogenic fatty hilum is a key criterion for selecting lymph nodes for fine-needle aspiration biopsy 1

Cervical Cancer

  • Loss of normal fatty hilum on MRI, along with rounded shape and heterogeneous signal, indicates abnormal pelvic or para-aortic lymph nodes 1
  • These morphologic criteria perform comparably to PET imaging for nodal staging 1

Oral Cavity Squamous Cell Carcinoma

  • Disrupted fatty hilum is independently predictive of occult nodal metastases (OR = 3.31, p = .04) even in sub-centimeter lymph nodes 4
  • When combined with round/oval shape and asymmetric number, disrupted fatty hilum achieves 93.8% positive predictive value for metastatic disease 4

Important Clinical Pitfalls

When Fatty Hilum is Present

  • Lymph nodes with preserved fatty hilum and benign morphology require no imaging follow-up or biopsy, as malignancy risk is extremely low 5
  • Nodes <10 mm in short axis with fatty hilum are consistently benign 5
  • Even if nodes are hypermetabolic on PET/CT, preserved fatty hilum suggests reactive rather than metastatic etiology—always obtain vaccination history 3

When Fatty Hilum is Absent

  • Absence of fatty hilum warrants percutaneous biopsy in the appropriate clinical context (known primary malignancy) 1
  • This finding alone has the highest positive predictive value among ultrasound features for malignancy 1
  • Must be interpreted with other features: cortical thickness, shape (round vs. oval), size, and vascular pattern 1

Rare Exceptions

  • Abundant macroscopic fat replacement of lymph nodes can occur in chronic lymphocytic leukemia, but this represents diseased rather than normal nodes 6
  • Fatty infiltration of lymph nodes can occur with renal angiomyolipoma, representing local aggressive behavior rather than malignancy 7
  • These scenarios are distinctly different from the normal fatty hilum and represent pathologic fat deposition 6, 7

Practical Assessment Algorithm

For any lymph node evaluation:

  1. First assess for presence of fatty hilum on ultrasound (echogenic center) or CT (low-density center) 1, 2
  2. If fatty hilum is present AND node is <10-15 mm AND oval-shaped: benign, no further workup needed 5
  3. If fatty hilum is absent OR disrupted: assess cortical thickness, shape, size, and vascularity 1, 4
  4. If multiple suspicious features present: proceed to biopsy in patients with known malignancy 1, 4

1, 5, 3, 4, 2

Related Questions

What is the management approach for two nonenlarged fatty hilum (fatty tissue in the center of a lymph node) containing groin lymph nodes without additional clinical concern or symptoms?
How to evaluate infiltration of interior abdominal fat with mildly enlarged lymph nodes?
What is the diagnosis and management for a hypermetabolic breast lesion with potential axillary metastases and pancreatic hypodense areas?
What is the significance of prominent right axillary lymph nodes (lymph nodes in the armpit) up to 0.9 cm in a patient with a history of smoking?
What is the next step in management for a breast cancer survivor with new hypermetabolic perihilar adenopathy on a positron emission tomography (PET) scan?
Does Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) increase bilirubin levels in patients, particularly those with pre-existing liver disease such as hepatitis B or C?
What is the recommended treatment for a patient presenting with a stye?
What is the initial treatment approach for a patient diagnosed with Autoimmune Hemolytic Anemia (AIHA)?
What is the diagnosis and management for a patient with pancytopenia (low blood cell count) for 3 months, macrocytic anemia (Mean Corpuscular Volume (MCV) 119), normal vitamin B12 levels, and no bleeding manifestations, with a possible consideration of aplastic anemia?
What is the initial management approach for a patient with lymphoma experiencing B symptoms, including fever, night sweats, and unintentional weight loss?
What are the indications for dialysis in a patient with lymphoma, B symptoms, and impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.